Viral hepatitis encompasses five major strains, from A to E, causing liver inflammation, acute symptoms, and varying risks of chronic disease.

Viral hepatitis remains a significant global health issue, involving inflammation of the liver caused by a group of distinct infectious agents classified alphabetically from type A to E [1], [2]. While these viruses share a common target organ, their transmission methods, clinical courses, and long-term health impacts vary considerably [1], [2]. Understanding these differences helps clarify how infections are acquired, how they manifest in the body, and what medical approaches are available for management.

The Spectrum of Viral Hepatitis Types

The five main types of viral hepatitis are caused by unique viruses with distinct properties:

Hepatitis A (HAV): Typically transmitted through the fecal-oral route, often via contaminated food, water, or close personal contact, and does not cause chronic liver disease [3], [4].
Hepatitis B (HBV): Spread through contact with infectious body fluids, such as blood. It can lead to chronic infection, particularly when acquired during childhood [1], [3].
Hepatitis C (HCV): Primarily transmitted through blood exposure. Like hepatitis B, it can become chronic and lead to long-term liver complications [1].
Hepatitis D (HDV): A unique satellite virus that can only replicate in the presence of hepatitis B, making co-infections particularly severe [2].
Hepatitis E (HEV): Another enterically transmitted virus, commonly spread via contaminated water or undercooked meat, posing specific risks during pregnancy and in immunocompromised individuals [2], [6], [7].

Recognizing Symptoms and Acute Presentation

In many cases, acute viral infections present noticeable symptoms, although children infected with hepatitis A often experience asymptomatic infections [4]. When adults contract hepatitis A, they frequently exhibit jaundice, abdominal pain, overall hepatitis inflammation, and high levels of bilirubin in the blood [4]. Across various acute viral hepatitis types, signs can include general malaise and digestive discomfort. Diagnosis relies heavily on a thorough medical history assessing risk factors, alongside specific serological tests to detect antibodies or antigens [3], [5]. In rare instances, acute viral hepatitis can escalate to acute liver failure, marked by continuous vomiting, altered consciousness, and abnormal clotting times, which require urgent medical evaluation [3].

Differentiating Viral Hepatitis from Autoimmune Hepatitis

When clinicians evaluate patients presenting with symptoms of liver inflammation and negative viral serology results, they must consider alternative origins [3]. One such condition is autoimmune hepatitis (AIH), an inflammatory pathology where the body's immune system attacks the liver [8]. Unlike viral strains, autoimmune hepatitis is diagnosed through the identification of specific autoantibodies, biochemical markers, and characteristic tissue biopsy features [8]. If left untreated, autoimmune hepatitis can similarly progress to cirrhosis and severe liver damage, sometimes necessitating a liver transplant [8].

Current Approaches to Treatment and Management

Management strategies differ substantially depending on the specific type of hepatitis and whether the infection is acute or chronic [1], [2].

Hepatitis A and E: Infections are frequently self-limiting and managed primarily with supportive care, rest, and hydration [2], [4], [7]. Outbreaks can be curbed through improved sanitation, hygiene awareness, and safe food practices [1].
Hepatitis B and C: Modern medicine has introduced highly effective curative regimens for clearing hepatitis C, as well as safe, tolerable medications that suppress hepatitis B activity to slow disease progression and prevent severe liver damage [1].

For individuals with severe, end-stage liver disease or acute liver failure unresponsive to other therapies, advanced interventions such as liver transplantation may be considered [3], [8].

Prevention Through Vaccination and Public Health

Prevention remains the most powerful defense against viral hepatitis [2]. Highly effective and safe vaccines are available to provide long-lasting immunity against both hepatitis A and hepatitis B [1], [3]. Routine vaccination before potential exposure is strongly recommended to curb transmission rates globally [1], [4]. Continued public health education, screening, and improved sanitation infrastructure remain vital tools in reducing the global burden of viral hepatitis [1].

Sources

This article summarises published research for a general audience. It is not medical advice — talk to a qualified clinician about your own situation. Need help finding one? Browse doctors.